Incyte Corporation (INCY)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-Market:
| Previous Close | 52.35 |
| Open | 52.51 |
| Bid | 51.88 x 600 |
| Ask | 51.94 x 600 |
| Day's Range | 51.88 - 52.61 |
| 52 Week Range | 50.27 - 75.74 |
| Volume | |
| Avg. Volume | 1,730,346 |
| Market Cap | 11.657B |
| Beta (5Y Monthly) | 0.67 |
| PE Ratio (TTM) | 19.59 |
| EPS (TTM) | 2.65 |
| Earnings Date | Apr 30, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 74.88 |
Business WireIncyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists
WILMINGTON, Del. & SAN DIEGO, April 23, 2024--Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists
Simply Wall St.The past three years for Incyte (NASDAQ:INCY) investors has not been profitable
For many investors, the main point of stock picking is to generate higher returns than the overall market. But the risk...
ZacksWant Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
© 2024 Yahoo. All rights reserved.